The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Cancer Anorexia-Cachexia Syndrome: Current Issues in Research and Management
Open accessAbstract
Cachexia is among the most debilitating and life-threatening aspects of cancer. Associated with anorexia, fat and muscle tissue wasting, psychological distress, and a lower quality of life, cachexia arises from a complex interaction between the cancer and the host. This process includes cytokine production, release of lipid-mobilizing and proteolysis-inducing factors, and alterations in intermediary metabolism. Cachexia should be suspected in patients with cancer if an involuntary weight loss of greater than five percent of premorbid weight occurs within a six-month period. The two major options for pharmacological therapy have been either progestational agents, such as megestrol acetate, or corticosteroids. However, knowledge of the mechanisms of cancer anorexia-cachexia syndrome has led to, and continues to lead to, effective therapeutic interventions for several aspects of the syndrome. These include antiserotonergic drugs, gastroprokinetic agents, branched-chain amino acids, eicosapentanoic acid, cannabinoids, melatonin, and thalidomide--all of which act on the feeding-regulatory circuitry to increase appetite and inhibit tumor-derived catabolic factors to antagonize tissue wasting and/or host cytokine release. Because weight loss shortens the survival time of cancer patients and decreases performance status, effective therapy would extend patient survival and improve quality of life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Central nervous system control of food intake
Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J., & Baskin, D. G. (2000) · Nature · doi:10.1038/35007534 · Cited by 6,451
Leptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
Role of leptin in the neuroendocrine response to fasting
Ahima, R. S., Prabakaran, D., Mantzoros, C., Qu, D., Lowell, B., Maratos-Flier, E., & Flier, J. S. (1996) · Nature · doi:10.1038/382250a0 · Cited by 3,117
Thalidomide is an inhibitor of angiogenesis.
D'Amato, R. J., Loughnan, M. S., Flynn, E., & Folkman, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.4082 · Cited by 2,454
Prognostic effect of weight loss prior tochemotherapy in cancer patients
Dewys, W. D., Begg, C., Lavin, P. T., Band, P. R., Bennett, J. M., Bertino, J. R., Cohen, M. H., Douglass, H. O., Engstrom, P. F., Ezdinli, E. Z., et al. (1980) · The American Journal of Medicine · doi:10.1016/s0149-2918(05)80001-3 · Cited by 2,354
Leptin-regulated endocannabinoids are involved in maintaining food intake
Di Marzo, V., Goparaju, S. K., Wang, L., Liu, J., Bátkai, S., Járai, Z., Fezza, F., Miura, G. I., Palmiter, R. D., Sugiura, T., et al. (2001) · Nature · doi:10.1038/35071088 · Cited by 1,559
Interacting Appetite-Regulating Pathways in the Hypothalamic Regulation of Body Weight
Kalra, S. P. (1999) · Endocrine Reviews · doi:10.1210/er.20.1.68 · Cited by 1,554
Interacting Appetite-Regulating Pathways in the Hypothalamic Regulation of Body Weight*
Kalra, S. P., Dube, M. G., Pu, S., Xu, B., Horvath, T. L., & Kalra, P. S. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.1.0357 · Cited by 1,552
Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.
Masferrer, J. L., Leahy, K. M., Koki, A. T., Zweifel, B. S., Settle, S. L., Woerner, B. M., Edwards, D. A., Flickinger, A. G., Moore, R. J., & Seibert, K. (2000) · PubMed · Cited by 1,401
Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin
Asakawa, A., Inui, A., Kaga, O., Yuzuriha, H., Nagata, T., Ueno, N., Makino, S., Fujimiya, M., Niijima, A., Fujino, M. A., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.22158 · Cited by 1,177
Self-citationSignals That Regulate Food Intake and Energy Homeostasis
Woods, S. C., Seeley, R. J., Porte, D., & Schwartz, M. W. (1998) · Science · doi:10.1126/science.280.5368.1378 · Cited by 1,169
NF-κB-Induced Loss of MyoD Messenger RNA: Possible Role in Muscle Decay and Cachexia
Guttridge, D. C., Mayo, M. W., Madrid, L. V., Wang, C.-Y., & Baldwin Jr., A. S. (2000) · Science · doi:10.1126/science.289.5488.2363 · Cited by 924
The Body Cell Mass and Its Supporting Environment
Bouman, H. D. (1963) · Physical Therapy · doi:10.1093/ptj/43.9.695a · Cited by 625
Klein, S., Kinney, J., Jeejeebhoy, K., Alpers, D., Hellerstein, M., Murray, M., & Twomey, P. (1997) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607197021003133 · Cited by 565
Unraveling the central nervous system pathways underlying responses to leptin
Elmquist, J. K., Maratos-Flier, E., Saper, C. B., & Flier, J. S. (1998) · Nature Neuroscience · doi:10.1038/2164 · Cited by 520
What’s in a Name? In Search of Leptin’s Physiologic Role1
Flier, J. S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.5.4779 · Cited by 518
Tisdale, M. J. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.23.1763 · Cited by 487
Barber, M. D., Ross, J. A., Voss, A. C., Tisdale, M. J., & Fearon, K. C. H. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690654 · Cited by 459
Characterization of a cancer cachectic factor
Todorov, P., Cariuk, P., McDevitt, T., Coles, B., Fearon, K., & Tisdale, M. (1996) · Nature · doi:10.1038/379739a0 · Cited by 437
Hypothalamic dopamine and serotonin in the regulation of food intake
Meguid, M. M., Fetissov, S. O., Varma, M., Sato, T., Zhang, L., Laviano, A., & Rossi-Fanelli, F. (2000) · Nutrition · doi:10.1016/s0899-9007(00)00449-4 · Cited by 423
Nutritional support of the cancer patient: issues and dilemmas
Nitenberg, G., & Raynard, B. (2000) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00048-2 · Cited by 421
Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma.
Blay, J., Négrier, S., Combaret, V., Attali, S., Goillot, E., Merrouche, Y., Mercatello, A., Ravault, A., Tourani, J. M., & Jf, M. (1992) · PubMed · Cited by 420
Ghrelin: An orexigenic and somatotrophic signal from the stomach
Inui, A. (2001) · Nature Reviews Neuroscience · doi:10.1038/35086018 · Cited by 396
Self-citationBruera, E. D., Roca, E. L., Cedaro, L., Carraro, S., & Chacon, R. (1985) · PubMed · Cited by 348
Loprinzi, C. L., Kugler, J. W., Sloan, J. A., Mailliard, J. A., Krook, J. E., Wilwerding, M. B., Rowland, K. M., Camoriano, J. K., Novotny, P. J., & Christensen, B. J. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3299 · Cited by 343
Cancer anorexia-cachexia syndrome: are neuropeptides the key?
Inui, A. (1999) · PubMed · Cited by 342
Self-citationReeds, P. J., Fjeld, C. R., & Jahoor, F. (1994) · The Journal of Nutrition · doi:10.1093/jn/124.6.906 · Cited by 335
Controlled Trial of Megestrol Acetate for the Treatment of Cancer Anorexia and Cachexia
Loprinzi, C. L., Ellison, N. M., Schaid, D. J., Krook, J. E., Athmann, L. M., Dose, A. M., Mailliard, J. A., Johnson, P. S., Ebbert, L. P., & Geeraerts, L. H. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.13.1127 · Cited by 318
Feeding and body-weight regulation by hypothalamic neuropeptides—mediation of the actions of leptin
Inui, A. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01292-2 · Cited by 318
Self-citationABC of palliative care: Anorexia, cachexia, and nutrition
Bruera, E. (1997) · BMJ · doi:10.1136/bmj.315.7117.1219 · Cited by 311
Gogos, C. A., Ginopoulos, P., Salsa, B., Apostolidou, E., Zoumbos, N. C., & Kalfarentzos, F. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980115)82:2<403::aid-cncr21>3.0.co;2-1 · Cited by 311
Lundholm, K., Gélin, J., Hyltander, A. G., Lönnroth, C., Sandström, R., Svaninger, G., Körner, U., Gulich, M. P., Kärrefors, I., & Norli, B. (1994) · PubMed · Cited by 309
Learned Taste Aversions in Children Receiving Chemotherapy
Bernstein, I. L. (1978) · Science · doi:10.1126/science.663613 · Cited by 305
Wigmore, S. J., Ross, J. A., Stuart Falconer, J., Plester, C. E., Tisdale, M. J., Carter, D. C., & Ch Fearon, K. (1996) · Nutrition · doi:10.1016/0899-9007(95)00078-x · Cited by 297
Role of the central melanocortin system in cachexia.
Marks, D. L., LING, N. C., & Cone, R. D. (2001) · PubMed · Cited by 291
Protein-calorie undernutrition in hospitalized cancer patients
Nixon, D. W., Heymsfield, S. B., Cohen, A. E., Kutner, M. H., Ansley, J., Lawson, D. H., & Rudman, D. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90254-5 · Cited by 284
Central nervous system mechanisms contributing to the cachexia–anorexia syndrome
Plata-Salamán, C. R. (2000) · Nutrition · doi:10.1016/s0899-9007(00)00413-5 · Cited by 271
The cancer anorexia-cachexia syndrome.
Nelson, K. A., Walsh, D., & Sheehan, F. A. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.1.213 · Cited by 265
Neuroendocrine Responses to Starvation and Weight Loss
Schwartz, M. W., & Seeley, R. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706193362507 · Cited by 265
Corticosteroid therapy of preterminal gastrointestinal cancer
Moertel, C. G., Schutt, A. J., Reitemeier, R. J., & Hahn, R. G. (1974) · Cancer · doi:10.1002/1097-0142(197406)33:6<1607::aid-cncr2820330620>3.0.co;2-v · Cited by 258
Gélin, J., Moldawer, L. L., Lönnroth, C., Sherry, B. A., Chizzonite, R., & Lundholm, K. (1991) · PubMed · Cited by 251
Abnormalities of taste sensation in cancer patients
DeWys, W. D., & Walters, K. (1975) · Cancer · doi:10.1002/1097-0142(197511)36:5<1888::aid-cncr2820360546>3.0.co;2-y · Cited by 251
Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients.
Hirai, K., Hussey, H., Barber, M. D., Price, S. A., & Tisdale, M. J. (1998) · PubMed · Cited by 244
Gastrointestinal Toxicity of Chemotherapeutic Agents
Mitchell, E. P. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.12.001 · Cited by 242
Body-composition changes in patients who gain weight while receiving megestrol acetate.
Loprinzi, C. L., Schaid, D. J., Dose, A. M., Burnham, N. L., & Jensen, M. D. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.1.152 · Cited by 230
Reversal of Cancer Anorexia by Blockade of Central Melanocortin Receptors in Rats
Wisse, B. E., Frayo, R. S., Schwartz, M. W., & Cummings, D. E. (2001) · Endocrinology · doi:10.1210/en.142.8.3292 · Cited by 226
Recent clinical experience with dronabinol
Plasse, T. F., Gorter, R. W., Krasnow, S. H., Lane, M., Shepard, K. V., & Wadleigh, R. G. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90385-f · Cited by 224
Tisdale, M. J. (2001) · Nutrition · doi:10.1016/s0899-9007(01)00506-8 · Cited by 224
Loprinzi, C. L., Michalak, J. C., Schaid, D. J., Mailliard, J. A., Athmann, L. M., Goldberg, R. M., Tschetter, L. K., Hatfield, A. K., & Morton, R. F. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.4.762 · Cited by 223
Staal-van den Brekel, A. J., Dentener, M. A., Schols, A. M., Buurman, W. A., & Wouters, E. F. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.10.2600 · Cited by 218
Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover.
Beck, S., Smith, K. L., & Tisdale, M. J. (1991) · PubMed · Cited by 216
A World Health Organizadon Demonstration Project, Nelson, K., Walsh, D., Deeter, P., & Sheehan, F. (1994) · Journal of Palliative Care · doi:10.1177/082585979401000105 · Cited by 215
Opioids and food intake: distributed functional neural pathways?
Glass, M. J., Billington, C. J., & Levine, A. S. (1999) · Neuropeptides · doi:10.1054/npep.1999.0050 · Cited by 203
Matthys, P., & Billiau, A. (1997) · Nutrition · doi:10.1016/s0899-9007(97)00185-8 · Cited by 201
Wigmore, S. J., Fearon, K. C. H., Maingay, J. P., & Ross, J. A. (1997) · Clinical Science · doi:10.1042/cs0920215 · Cited by 195
A review of cancer cachexia and abnormal glucose metabolism in humans with cancer.
Tayek, J. A. (1992) · Journal of the American College of Nutrition · doi:10.1080/07315724.1992.10718249 · Cited by 194
Goldberg, R. M., Loprinzi, C. L., Mailliard, J. A., O'Fallon, J. R., Krook, J. E., Ghosh, C., Hestorff, R. D., Chong, S. F., Reuter, N. F., & Shanahan, T. G. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.11.2856 · Cited by 184
Skeletal muscle metabolism in patients with malignant tumor
Lundholm, K., Bylund, A.-C., Holm, J., & Scherstén, T. (1976) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(76)90036-0 · Cited by 180
Prednisolone as an appetite stimulant in patients with cancer.
Willox, J. C., Corr, J., Shaw, J., Richardson, M., Calman, K. C., & Drennan, M. (1984) · BMJ · doi:10.1136/bmj.288.6410.27 · Cited by 180
Anorexia induced by cytokine interactions at pathophysiological concentrations
Sonti, G., Ilyin, S. E., & Plata-Salaman, C. R. (1996) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1996.270.6.r1394 · Cited by 180
Hypothalamic response to starvation: implications for the study of wasting disorders
Schwartz, M. W., Dallman, M. F., & Woods, S. C. (1995) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1995.269.5.r949 · Cited by 177
Pancreatic Cancer as a Model: Inflammatory Mediators, Acute‐phase Response, and Cancer Cachexia
Fearon, K. C. H., Barber, M. D., Falconer, J. S., McMillan, D. C., Ross, J. A., & Preston, T. (1999) · World Journal of Surgery · doi:10.1007/pl00012351 · Cited by 175
McMillan, D. C., Wigmore, S. J., Wigmore, K. C. H., O’Gorman, P., Wright, C. E., & McArdle, C. S. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690077 · Cited by 174
Transgenic Approach to the Study of Body Weight Regulation
Inui, A. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01435-2 · Cited by 174
Self-citationMethylprednisolone as palliative therapy for female terminal cancer patients
Metz, C. A., Popiela, T., Lucchi, R., & Giongo, F. (1989) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(89)90354-4 · Cited by 173
Managing Cancer-Related Anorexia/Cachexia
Mantovani, G., Macci??, A., Massa, E., & Madeddu, C. (2001) · Drugs · doi:10.2165/00003495-200161040-00004 · Cited by 168
The MONA LISA hypothesis in the time of leptin.
Bray, G. A., & York, D. A. (1998) · PubMed · Cited by 164
CANCER CACHEXIA AND PROTEIN METABOLISM
Jeevanandam, M., Lowry, S., Horowitz, G. D., et al. (1984) · The Lancet · doi:10.1016/s0140-6736(84)91929-9 · Cited by 162
Mantovani, G., Macciò, A., Lai, P., Massa, E., Ghiani, M., & Santona, M. C. (1998) · PubMed · Cited by 158
Klausner, J. D., Makonkawkeyoon, S., Akarasewi, P., Nakata, K., Kasinrerk, W., Corral, L. G., Dewar, R. L., Lane, H. C., Freedman, V. H., & Kaplan, G. (1996) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199603010-00005 · Cited by 154
Megestrol acetate in cancer anorexia and weight loss
Tchekmedyian, N. S., Hickman, M., Siau, J., Greco, F. A., Keller, J. W., Browder, H. P., & Aisner, J. (1992) · Cancer · doi:10.1002/cncr.2820690532 · Cited by 153
Smith, K., & Tisdale, M. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.126 · Cited by 149
Maltoni, M. C., Nanni, O., Scarpi, E., Rossi, D., Serra, P., & Amadori, D. (2001) · Annals of Oncology · doi:10.1023/a:1011156811739 · Cited by 147
Costelli, P., Garcia‐Martínez, C., Llovera, M., Carbó, N., López-Soriano, F. J., Agell, N., Tessitore, L., Baccino, F. M., & Argilés, J. M. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117929 · Cited by 142
Is there a role for melatonin in the treatment of neoplastic cachexia?
Lissoni, P., Paolorossi, F., Tancini, G., Barni, S., Ardizzoia, A., Brivio, F., Zubelewicz‐Szkodzińska, B., & Chatikhine, V. A. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00136-0 · Cited by 140
Anorexia as a general effect of cancer
DeWys, W. D. (1979) · Cancer · Cited by 129
Central nervous system action of peptides to influence gastrointestinal motor function
Taché, Y., Garrick, T., & Raybould, H. E. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90849-v · Cited by 127
Regulation of skeletal-muscle–protein turnover in cancer-associated cachexia
Baracos, V. E. (2000) · Nutrition · doi:10.1016/s0899-9007(00)00407-x · Cited by 127
Clenbuterol, a β-Adrenoceptor Agonist, Increases Relative Muscle Strength in Orthopaedic Patients
Maltin, C. A., Delday, M. I., Watson, J. S., Heys, S. D., Nevison, I. M., Ritchie, I. K., & Gibson, P. H. (1993) · Clinical Science · doi:10.1042/cs0840651 · Cited by 126
Lissoni, P., Paolorossi, F., Ardizzoia, A., Barni, S., Chilelli, M. G., Mancuso, M., Tancini, G., Conti, A. M. F., & Maestroni, G. J. M. (1997) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1997.tb00329.x · Cited by 115
Tayek, J. A., Bistrian, B. R., Hehir, D., Martín, R., Moldawer, L. L., & Blackburn, G. L. (1986) · Cancer · Cited by 114
The Role of Cytokines in Cancer Cachexia
Moldawer, L. L., Rogy, M. A., & Lowry, S. F. (1992) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860719201600602 · Cited by 109
Loprinzi, C. L., Kuross, S. A., O'Fallon, J. R., Gesme, D. H., Gerstner, J. B., Rospond, R. M., Cobau, C. D., & Goldberg, R. M. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.6.1121 · Cited by 107
McCarthy, H. D., Crowder, R., Dryden, S. D., & Williams, G. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90229-1 · Cited by 105
Peptidergic regulation of gastrointestinal motility in rodents
Fujimiya, M., & Inui, A. (2000) · Peptides · doi:10.1016/s0196-9781(00)00313-2 · Cited by 104
Self-citationNeuropeptide Y blocks and reverses interleukin-1β-induced anorexia in rats
Sonti, G., Ilyin, S. E., & Plata‐Saláman, C. R. (1996) · Peptides · doi:10.1016/0196-9781(96)00016-2 · Cited by 103
Inhibition of lipolysis and muscle protein degradation by EPA in cancer cachexia
Tisdale, M. J. (1996) · Nutrition · doi:10.1016/0899-9007(96)90015-5 · Cited by 102
A Review of the Drug Treatment of Cachexia Associated with Cancer
Gagnon, B., & Bruera, E. D. (1998) · Drugs · doi:10.2165/00003495-199855050-00005 · Cited by 99
Brain cytokine mRNAs in anorectic rats bearing prostate adenocarcinoma tumor cells
Plata‐Saláman, C. R., Ilyin, S. E., & Gayle, D. A. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.275.2.r566 · Cited by 99
Wigmore, S. J., Falconer, J. S., Plester, C. E., et al. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.300 · Cited by 98
The cancer anorexia-cachexia syndrome.
Nelson, K. A. (2000) · PubMed · Cited by 98
Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer
Chlebowski, R. T., Herrold, J. N., Ali, I., Oktay, E., Chlebowski, J. S., Ponce, A. T., Heber, D., & Block, J. B. (1986) · Cancer · doi:10.1002/1097-0142(19860701)58:1<183::aid-cncr2820580131>3.0.co;2-3 · Cited by 97
Metabolic abnormalities in cachexia and anorexia
Tisdale, M. J. (2000) · Nutrition · doi:10.1016/s0899-9007(00)00409-3 · Cited by 95
Central Nervous System IL-1β System and Neuropeptide Y mRNAs During IL-1β-induced Anorexia in Rats
Gayle, D. A., Ilyin, S. E., & Plata‐Saláman, C. R. (1997) · Brain Research Bulletin · doi:10.1016/s0361-9230(97)00159-7 · Cited by 95
Protein Loss in Cancer Cachexia
Tisdale, M. J. (2000) · Science · doi:10.1126/science.289.5488.2293 · Cited by 89
Cangiano, C., Laviano, A., Meguid, M. M., Mulieri, M., Conversano, L., Preziosa, I., & Fanelli, F. R. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.8.550 · Cited by 89
Cracking the riddle of cancer anorexia
Laviano, A., Meguid, M. M., Yang, Z., Gleason, J. R., Cangiano, C., & Fanelli, F. R. (1996) · Nutrition · doi:10.1016/s0899-9007(96)00164-5 · Cited by 85
Cancer cachexia: A therapeutic approach
Argilés, J. M. A., Meijsing, S. H., Pallarés‐Trujillo, J., Guirao, X., & López-Soriano, F. J. (2000) · Medicinal Research Reviews · doi:10.1002/1098-1128(200101)21:1<83::aid-med4>3.0.co;2-1 · Cited by 78
Cachexia and anorexia: cancer's covert killer
Davis, M. P., & Dickerson, E. D. (2000) · Supportive Care in Cancer · doi:10.1007/s005200050282 · Cited by 78
Are cytokines possible mediators of cancer cachexia?
Noguchi, Y., Yoshikawa, T., Matsumoto, A., Svaninger, G., & Gelin, J. (1996) · Surgery today (Print) · doi:10.1007/bf00311551 · Cited by 73
Analysis of the energy balance in lung cancer patients
den Brekel, A. J. S.-V. (1995) · Lung Cancer · doi:10.1016/0169-5002(95)98799-g · Cited by 70
Bruera, E. D., MacEachern, T., Spachynski, K., LeGatt, D. F., MacDonald, R. N., Babul, N., Harsanyi, Z., & Darke, A. C. (1994) · Cancer · Cited by 66
Cytokines and sickness behavior: implications from knockout animal models
Inui, A. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01981-0 · Cited by 61
Self-citationTime‐Dependent Variation in Weight and Body Composition in Healthy Adults
Rosenbaum, K., Wang, J., Pierson, R. N., & Kotler, D. P. (2000) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860710002400252 · Cited by 58
Chance, W. T., Balasubramaniam, A., Thompson, H., Mohapatra, B. N., Ramo, J., & Fischer, J. E. (1996) · Peptides · doi:10.1016/0196-9781(96)00108-8 · Cited by 55
Moertel, C. G., Kvols, L. K., & Rubin, J. (1991) · Cancer · Cited by 53
The syndrome of anorexia-cachexia
Body, J. J. (1999) · Current Opinion in Oncology · doi:10.1097/00001622-199907000-00004 · Cited by 49
Belizário, J. E., Katz, M., Chenker, E., & Raw, I. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.159 · Cited by 47
Jensen, P. B., Blume, N., Mikkelsen, J. D., Larsen, P. J., Jensen, H. I., Holst, J. J., & Madsen, O. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci275 · Cited by 45
Thwarting the dwindling progression of cachexia
Larkin, M. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79068-1 · Cited by 44
Neuropeptide Y: a key molecule in anorexia and cachexia in wasting disorders?
Inui, A. (1999) · Molecular Medicine Today · doi:10.1016/s1357-4310(98)01395-1 · Cited by 44
Self-citationMcMillan, D. C., Leen, E. L. S., Smith, J., Sturgeon, C., Preston, T., Cooke, T. G., & McArdle, C. S. (1995) · European Journal of Surgical Oncology · doi:10.1016/s0748-7983(95)97157-2 · Cited by 42
Transgenic study of energy homeostasis equation: implications and confounding influences
Inui, A. (2000) · The FASEB Journal · doi:10.1096/fj.00-0291rev · Cited by 40
Self-citationDelayed gastric emptying in bulimic patients
Inui, A., Okano, H., Miyamoto, M., Aoyama, N., Uemoto, M., Baba, S., & Kasuga, M. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92954-1 · Cited by 33
Self-citationEditorial: Hypothalamic Melanocortin Signaling in Cachexia
Lechan, R. M., & Tatro, J. B. (2001) · Endocrinology · doi:10.1210/endo.142.8.8408 · Cited by 30
Costa, A. M., Spence, K. T., Plata‐Saláman, C. R., & ffrench-Mullen, J. M. H. (1995) · The Journal of Physiology · doi:10.1113/jphysiol.1995.sp020880 · Cited by 29
Okano, H., Inui, A., Ueno, N., Morimoto, S., Ohmoto, A., Miyamoto, M., Aoyama, N., Nakajima, Y., Baba, S., & Kasuga, M. (1996) · Peptides · doi:10.1016/0196-9781(96)00143-x · Cited by 22
Self-citationFatigue and cachexia in cancer patients
Glaus, A. (1998) · Supportive Care in Cancer · doi:10.1007/s005200050137 · Cited by 18
Goldberg, R. M., & Loprinzi, C. L. (1999) · Cancer treatment and research · doi:10.1007/978-1-4615-5003-7_2 · Cited by 17
Metabolic sequelae of cancers (excluding bone marrow transplantation)
Body, J. (1999) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-199907000-00016 · Cited by 17
Palliative Care and Rehabilitation of Cancer Patients
(1999) · Cancer treatment and research · doi:10.1007/978-1-4615-5003-7 · Cited by 13
Lipton (1995) · Pure Amsterdam UMC · doi:10.1002/1097-0142(19950415)75:8 · Cited by 1
(1997) · doi:10.1002/(sici)1097-0142(19970501)79:9
Cited by
Paraneoplastic Syndromes Involving the Nervous System
Darnell, R. B., & Posner, J. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023009 · Cited by 1,062
Cachexia: pathophysiology and clinical relevance1,2
Morley, J. E., Thomas, D. R., & Wilson, M.-M. G. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.4.735 · Cited by 786
ESMO Symposium on Immuno-Oncology 2015 Officers and Organisation
(2015) · Annals of Oncology · doi:10.1093/annonc/ · Cited by 733
Bonini, S. A., Premoli, M., Tambaro, S., Kumar, A., Maccarinelli, G., Memo, M., & Mastinu, A. (2018) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.09.004 · Cited by 669
Cannabinoids as Novel Anti-Inflammatory Drugs
Nagarkatti, P., Pandey, R., Rieder, S. A., Hegde, V. L., & Nagarkatti, M. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.93 · Cited by 555
“associated with cancer chemotherapy; anorexia and cachexia seen in HIV/AIDS patients; and in neuropathic pain and spasticity in multiple sclerosis [1–4].”
Metadata
- Authors
- Inui, A.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2002-03-01
- Volume
- 52
- Issue
- 2
- Pages
- 72-91
- ISSN
- 0007-9235 (ISSN-L)
- OpenAlex
- W1968272322
- Cited by
- 579
- References
- 123
- FWCI
- 14.88
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.